Brief: Elevation Oncology Highlights 2021 Achievements And Outlines Expected 2022 Milestones
10/01/2022 12:25
Jan 10 (Reuters) - Elevation Oncology Inc ELEV.O :
* ELEVATION ONCOLOGY HIGHLIGHTS 2021 ACHIEVEMENTS AND OUTLINES EXPECTED 2022
MILESTONES
* ELEVATION ONCOLOGY INC - ON TRACK TO PRESENT INITIAL CLINICAL DATA FROM
COHORT 1
OF PHASE 2 CRESTONE STUDY IN MID-2022
* ELEVATION ONCOLOGY INC - CO SEES CASH, CASH EQUIVALENTS, TOTALING $155.2
MILLION
AS OF SEPT 30, 2021, TO FUND CURRENT OPERATIONS INTO Q2 OF 2023
Source text for Eikon: ID:nPn38g7J8a
Further company coverage: ELEV.O
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing